Abstract: A crystalline form of phenyl bis (2,4,6-trimethylbenzoyl) phosphine oxide, with a large particle size, which belongs to a triclinic crystal system and space group P-1. A crystallization method for making the crystalline form of phenyl bis (2,4,6-trimethylbenzoyl) phosphine oxide, comprising adding a solid of phenyl bis (2,4,6-trimethylbenzoyl) phosphine oxide to a solvent and mixing; followed by heating to 50 to 70° C. to achieve complete dissolution; cooling the solution to room temperature; and adding an anti-solvent to the resulting solution to cause precipitation of crystals. The crystals are allowed to grow at a constant temperature for 10 to 60 minutes, so as to give a slurry containing the crystals. Said slurry is subjected to filtration and then drying to obtain the crystalline form of phenyl bis (2,4,6-trimethylbenzoyl) phosphine oxide.

Abstract: The disclosure relates to etoricoxib solvates and a preparation method thereof. A solvent is a hydrogen bond donor solvent with a polarity value ?* ranging from 60 to 100 or a hydrogen bond acceptor solvent with a polarity value ?* ranging from 92 to 100. Solvents with a polarity value ?* within the above range all can form corresponding etoricoxib solvates with etoricoxib. The etoricoxib solvate can be prepared by cooling crystallization or suspension crystallization. A 1,2-propanediol solvate of etoricoxib and a dimethyl sulfoxide (DMSO) solvate of etoricoxib provided in the present disclosure have high thermal stability, unique crystal form, large size, concentrated distribution, and prominent flowability and is safe, pharmaceutically acceptable, and not easy to agglomerate. Compared with etoricoxib, the etoricoxib solvates exhibit significantly improved solubility.

Abstract: The present application provides display panels, transparent display panels and manufacturing methods therefor. A transparent display panel includes a light transmitting substrate, pixel structures, second electrode connecting portions, and a nano-material layer. A display region of the light transmitting substrate includes alternately distributed pixel regions and non-pixel regions. The pixel structures are located in the pixel regions, each including: a first electrode close to the light transmitting substrate, a second electrode away from the light transmitting substrate, and a light emitting block between the first electrode and the second electrode. The second electrode connecting portions are located in the non-pixel regions, and connect adjacent second electrodes, and one or more materials for the second electrode connecting portions are the same as the one or more materials for the second electrodes, both including transflective materials.

Abstract: A display substrate has a display region. The display region includes at least a first region, and the first region includes a plurality of first sub-pixel regions. The display substrate includes: a substrate; a plurality of first sub-pixels disposed on a side of the substrate; and a pattern layer disposed on a side of the plurality of first sub-pixels away from the substrate. The pattern layer includes a first pattern and a plurality of second patterns. Boundaries of orthographic projections of part of the second patterns located in the first region on the substrate respectively coincide with boundaries of the first sub-pixel regions; or boundaries of the first sub-pixel regions are respectively located within boundaries of orthographic projections of part of the second patterns located in the first region on the substrate. A portion of the first pattern located in the first region is electrically connected to the first cathode.

Abstract: The disclosure relates to etoricoxib solvates and a preparation method thereof. A solvent is a hydrogen bond donor solvent with a polarity value ?* ranging from 60 to 100 or a hydrogen bond acceptor solvent with a polarity value ?* ranging from 92 to 100. Solvents with a polarity value ?* within the above range all can form corresponding etoricoxib solvates with etoricoxib. The etoricoxib solvate can be prepared by cooling crystallization or suspension crystallization. A 1,2-propanediol solvate of etoricoxib and a dimethyl sulfoxide (DMSO) solvate of etoricoxib provided in the present disclosure have high thermal stability, unique crystal form, large size, concentrated distribution, and prominent flowability and is safe, pharmaceutically acceptable, and not easy to agglomerate. Compared with etoricoxib, the etoricoxib solvates exhibit significantly improved solubility.

Abstract: A crystalline form of phenyl bis (2,4,6-trimethylbenzoyl) phosphine oxide, with a large particle size, which belongs to a triclinic crystal system and space group P-1. A crystallization method for making the crystalline form of phenyl bis (2,4,6-trimethylbenzoyl) phosphine oxide, comprising adding a solid of phenyl bis (2,4,6-trimethylbenzoyl) phosphine oxide to a solvent and mixing; followed by heating to 50 to 70° C. to achieve complete dissolution; cooling the solution to room temperature; and adding an anti-solvent to the resulting solution to cause precipitation of crystals. The crystals are allowed to grow at a constant temperature for 10 to 60 minutes, so as to give a slurry containing the crystals. Said slurry is subjected to filtration and then drying to obtain the crystalline form of phenyl bis (2,4,6-trimethylbenzoyl) phosphine oxide.

Abstract: A novel crystalline form is defined by diffraction angle 2?° of X-ray powder diffraction pattern and characteristic peak of differential scanning calorimetry (DSC). The novel crystalline form of Cefamandole Nafate is prepared as follows: adding Cefamandole Nafate in solid state to an organic solvent to form a suspension with a concentration of 0.04˜0.3 g/ml, stirring the suspension at 40˜50° C. for a period of time, and then cooling to 5˜15° C. at certain cooling rate, continuing to stir for a period of time, then suction filtrating the obtained suspension, the resulting filer cake is Cefamandole Nafate as wet product, which is dried to constant weight to provide the novel crystalline form of Cefamandole Nafate as final product.

Abstract: A novel crystalline form is defined by diffraction angle 2?° of X-ray powder diffraction pattern and characteristic peak of differential scanning calorimetry (DSC). The novel crystalline form of Cefamandole Nafate is prepared as follows: adding Cefamandole Nafate in solid state to an organic solvent to form a suspension with a concentration of 0.04˜0.3 g/ml, stirring the suspension at 40˜50° C. for a period of time, and then cooling to 5˜15° C. at certain cooling rate, continuing to stir for a period of time, then suction filtrating the obtained suspension, the resulting filer cake is Cefamandole Nafate as wet product, which is dried to constant weight to provide the novel crystalline form of Cefamandole Nafate as final product.

Abstract: It discloses Omeprazole Sodium semihydrate and preparation method thereof, wherein every mole of Omeprazole Sodium semihydrate contains 0.5 mole of water, and it has an X-ray diffraction pattern comprising characteristic peaks at diffraction angles 2? of 6.26°±0.1°, 11.10°±0.1°, 12.20°±0.1°, 15.58°±0.1°, 16.02°±0.1°, 17.12°±0.1°, 19.08°±0.1°, 21.00°±0.1°, 22.68°±0.1°, 23.48°±0.1°, 24.08°±0.1°, 26.52°±0.1° and 28.08°±0.1°. A raw material of Omeprazole Sodium hydrate is added into an organic solvent, stirring for 2˜9 hours at constant temperature of 25˜60° C., thereafter Omeprazole Sodium semihydrate is provided after filtrating and drying.

Abstract: A novel crystalline form of Cefathiamidine compound and its preparation method, characterizing in its X-ray powder diffraction pattern and differential scanning calorimetry thermogram. Dissolving Cefathiamidine compound with a purity of 98% or higher in a solvent at a temperature of 30˜45° C. to form a solution, whose concentration is controlled within 0.05˜0.2 g/mL, and then adding a solventing-out agent to the solution, wherein the amount of the solventing-out agent is 3˜5 times (in volume) of that of the solvent; followed by cooling the solution down to 0˜10° C. at a rate of 0.2˜1° C./min; continuing to stir for 1˜3 hours, and separating the obtained solid-liquid suspension to provide a novel crystalline form of Cefathiamidine compound after drying.

Abstract: A novel crystalline form is defined by diffraction angle 2?° of X-ray powder diffraction pattern and characteristic peak of differential scanning calorimetry (DSC). The novel crystalline form of Cefamandole Nafate is prepared as follows: adding Cefamandole Nafate in solid state to an organic solvent to form a suspension with a concentration of 0.04˜0.3 g/ml, stirring the suspension at 40˜50° C. for a period of time, and then cooling to 5˜15° C. at certain cooling rate, continuing to stir for a period of time, then suction filtrating the obtained suspension, the resulting filer cake is Cefamandole Nafate as wet product, which is dried to constant weight to provide the novel crystalline form of Cefamandole Nafate as final product.

Abstract: It discloses Omeprazole Sodium semihydrate and preparation method thereof, wherein every mole of Omeprazole Sodium semihydrate contains 0.5 mole of water, and it has an X-ray diffraction pattern comprising characteristic peaks at diffraction angles 2? of 6.26°±0.1°, 11.10°±0.1°, 12.20°±0.1°, 15.58°±0.1°, 16.02°±0.1°, 17.12°±0.1°, 19.08°±0.1°, 21.00°±0.1°, 22.68°±0.1°, 23.48°±0.1°, 24.08°±0.1°, 26.52°±0.1° and 28.08°±0.1°. A raw material of Omeprazole Sodium hydrate is added into an organic solvent, stirring for 2˜9 hours at constant temperature of 25˜60° C., thereafter Omeprazole Sodium semihydrate is provided after filtrating and drying.

Abstract: A novel crystalline form of Cefathiamidine compound and its preparation method, characterizing in its X-ray powder diffraction pattern and differential scanning calorimetry thermogram. Dissolving Cefathiamidine compound with a purity of 98% or higher in a solvent at a temperature of 30˜45° C. to form a solution, whose concentration is controlled within 0.05˜0.2 g/mL, and then adding a solventing-out agent to the solution, wherein the amount of the solventing-out agent is 3˜5 times (in volume) of that of the solvent; followed by cooling the solution down to 0˜10° C. at a rate of 0.2˜1° C./min; continuing to stir for 1˜3 hours, and separating the obtained solid-liquid suspension to provide a novel crystalline form of Cefathiamidine compound after drying.

Abstract: A reflection detection apparatus includes: a light-emitting surface; a detection light output portion to obliquely emit detection light from an emission area as a part of the light-emitting surface; a plurality of light-receiving devices to selectively receive, as reflected detection light, the detection light that is emitted to an external object from the emission area and enters the light-emitting surface with a predetermined angle after being reflected by the external object; and a height detection portion to obtain a height of a spot at which the detection light is reflected by the external object using positional information of the light-receiving device which has received the reflected detection light and positional information of the emission area, the height being a distance from the light-emitting surface.

Abstract: A surface light source device, which may perform surface light emission using a plurality of light guide members while suppressing formation of emission lines, and a display device using the surface light source device is provided. The surface light source device includes light sources, and a plurality of light guide members, each light guide member having a light incidence surface for light entering from each of the light sources, and making surface light emission based on incident light from the light incidence surface. The plurality of light guide members are arranged on the same plane, and each light guide member has tapered or curved surfaces adjacent to the light incidence surface, each tapered or curved surface having a predetermined angle against the light incidence surface.

Abstract: The present invention provides a backlight capable of suppressing loss of light from an invisible light source and a displaying/imaging apparatus using the same. The backlight includes: a light guide plate having a light emitting face and a rear face opposed to the light emitting face; a visible light source disposed on a side face of the light guide plate; an invisible light source disposed on a side face of the light guide plate; a first reflection film disposed on the rear face side of the light guide plate, reflecting light from the visible light source, and transmitting light from the invisible light source; and a second reflection film disposed on the rear face side of the light guide plate and reflecting light from at least the invisible light source out of the visible light source and the invisible light source.

Abstract: A surface emission apparatus includes a first light source for emitting invisible light rays; a second light source for emitting visible light rays; a light guide having a light entrance surface for entering therethrough into the light guide the invisible light rays emitted from the first light source and the visible light rays emitted from the second light source, and a light exit surface for emitting the invisible light rays and the visible light rays therethrough out of the light guide; and a plurality of optical devices disposed on a surface of the light guide which confronts the light exit surface, for scattering more of the invisible light rays than the visible light rays.

Abstract: Disclosed herein is a display device including, a visual target, and a backlight adapted to illuminate the visual target from the rear, the backlight including, a plurality of first light sources, second light sources, and a light guide plate, wherein the light guide plate has a plurality of projecting portions on a side surface portion thereof upon which the light, produced by the plurality of first and second light sources is incident, the projecting portions being arranged, along the side surface portion and project toward the one side of the given direction, the plurality of first light sources are disposed to be opposed to the tip surfaces of the plurality of projecting portions, and the second light sources are disposed to be opposed to the bottom surfaces of recessed portions formed between the plurality of projecting portions.

Abstract: Disclosed herein is a display device including, a visual target, and a backlight adapted to illuminate the visual target from the rear, the backlight including, a plurality of first light sources, second light sources, and a light guide plate, wherein the light guide plate has a plurality of projecting portions on a side surface portion thereof upon which the light, produced by the plurality of first and second light sources is incident, the projecting portions being arranged, along the side surface portion and project toward the one side of the given direction, the plurality of first light sources are disposed to be opposed to the tip surfaces of the plurality of projecting portions, and the second light sources are disposed to be opposed to the bottom surfaces of recessed portions formed between the plurality of projecting portions.

Abstract: The present invention provides a backlight capable of suppressing loss of light from an invisible light source and a displaying/imaging apparatus using the same. The backlight includes: a light guide plate having a light emitting face and a rear face opposed to the light emitting face; a visible light source disposed on a side face of the light guide plate; an invisible light source disposed on a side face of the light guide plate; a first reflection film disposed on the rear face side of the light guide plate, reflecting light from the visible light source, and transmitting light from the invisible light source; and a second reflection film disposed on the rear face side of the light guide plate and reflecting light from at least the invisible light source out of the visible light source and the invisible light source.